| Centro Medico, Inc. | |
|
11946 Hawthorne Blvd. Hawthorne CA 90250-3016 | |
| (310) 675-1136 | |
| (310) 970-1447 |
| Full Name | Centro Medico, Inc. |
|---|---|
| Speciality | Family Medicine |
| Location | 11946 Hawthorne Blvd., Hawthorne, California |
| Authorized Official Name and Position | Nabil Nazir Soliman (OWNER) |
| Authorized Official Contact | 3106751136 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Centro Medico, Inc. 11946 Hawthorne Blvd. Hawthorne CA 90250-3016 Ph: (310) 675-1136 | Centro Medico, Inc. 11946 Hawthorne Blvd. Hawthorne CA 90250-3016 Ph: (310) 675-1136 |
| NPI Number | 1497776322 |
|---|---|
| Provider Enumeration Date | 07/23/2006 |
| Last Update Date | 05/23/2023 |
| Medicare PECOS PAC ID | 2163617846 |
|---|---|
| Medicare Enrollment ID | O20101108000510 |
News Archive
Even though patients receiving an implantable cardioverter-defibrillator for primary prevention often receive a dual-chamber ICD, an analysis that included more than 32,000 patients receiving an ICD without indications for pacing finds that the use of a dual-chamber device compared with a single-chamber device was associated with a higher risk of device-related complications and similar 1-year mortality and hospitalization outcomes, according to a study in the May 15 issue of JAMA.
Weill Cornell Medical College announced today that it has received a $100 million gift from longtime benefactors Joan and Sanford I. Weill and the Weill Family Foundation to launch the Medical College's $300 million Driving Discoveries, Changing Lives campaign dedicated to using the most advanced scientific approaches to rapidly translate research breakthroughs into innovative treatments and therapies for patients.
Genomic Health, Inc. today reported financial results and business progress for the quarter ended March 31, 2010.
Infinity Pharmaceuticals, Inc., an innovative drug discovery and development company, today announced that data from its Hsp90 chaperone and Hedgehog pathway inhibitor programs will be presented during the 2010 American Society of Clinical Oncology (ASCO) Annual Meeting being held in Chicago, Ill. from June 4 through June 8, 2010.
Pfizer Inc. and DxS (a wholly owned subsidiary of QIAGEN N.V.) today announced that they have entered into an agreement to develop a companion diagnostic test kit for PF-04948568 (CDX-110), an immunotherapy vaccine in development for the treatment of glioblastoma multiforme (GBM).
› Verified 5 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497776322 | NPI | - | NPPES |
| GR0057390 | Medicaid | CA | |
| ZZZ39006Z | Other | CA | BLUE SHIELD PROVIDER # |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | (* (Not Available)) | Primary |
| Provider Name | Janet F Soliman |
|---|---|
| Provider Type | Practitioner - General Practice |
| Provider Identifiers | NPI Number: 1548295066 PECOS PAC ID: 6507051281 Enrollment ID: I20101108000544 |
News Archive
Even though patients receiving an implantable cardioverter-defibrillator for primary prevention often receive a dual-chamber ICD, an analysis that included more than 32,000 patients receiving an ICD without indications for pacing finds that the use of a dual-chamber device compared with a single-chamber device was associated with a higher risk of device-related complications and similar 1-year mortality and hospitalization outcomes, according to a study in the May 15 issue of JAMA.
Weill Cornell Medical College announced today that it has received a $100 million gift from longtime benefactors Joan and Sanford I. Weill and the Weill Family Foundation to launch the Medical College's $300 million Driving Discoveries, Changing Lives campaign dedicated to using the most advanced scientific approaches to rapidly translate research breakthroughs into innovative treatments and therapies for patients.
Genomic Health, Inc. today reported financial results and business progress for the quarter ended March 31, 2010.
Infinity Pharmaceuticals, Inc., an innovative drug discovery and development company, today announced that data from its Hsp90 chaperone and Hedgehog pathway inhibitor programs will be presented during the 2010 American Society of Clinical Oncology (ASCO) Annual Meeting being held in Chicago, Ill. from June 4 through June 8, 2010.
Pfizer Inc. and DxS (a wholly owned subsidiary of QIAGEN N.V.) today announced that they have entered into an agreement to develop a companion diagnostic test kit for PF-04948568 (CDX-110), an immunotherapy vaccine in development for the treatment of glioblastoma multiforme (GBM).
› Verified 5 days ago
| Provider Name | Nabil N Soliman |
|---|---|
| Provider Type | Practitioner - General Practice |
| Provider Identifiers | NPI Number: 1831114289 PECOS PAC ID: 6901091685 Enrollment ID: I20101108000625 |
News Archive
Even though patients receiving an implantable cardioverter-defibrillator for primary prevention often receive a dual-chamber ICD, an analysis that included more than 32,000 patients receiving an ICD without indications for pacing finds that the use of a dual-chamber device compared with a single-chamber device was associated with a higher risk of device-related complications and similar 1-year mortality and hospitalization outcomes, according to a study in the May 15 issue of JAMA.
Weill Cornell Medical College announced today that it has received a $100 million gift from longtime benefactors Joan and Sanford I. Weill and the Weill Family Foundation to launch the Medical College's $300 million Driving Discoveries, Changing Lives campaign dedicated to using the most advanced scientific approaches to rapidly translate research breakthroughs into innovative treatments and therapies for patients.
Genomic Health, Inc. today reported financial results and business progress for the quarter ended March 31, 2010.
Infinity Pharmaceuticals, Inc., an innovative drug discovery and development company, today announced that data from its Hsp90 chaperone and Hedgehog pathway inhibitor programs will be presented during the 2010 American Society of Clinical Oncology (ASCO) Annual Meeting being held in Chicago, Ill. from June 4 through June 8, 2010.
Pfizer Inc. and DxS (a wholly owned subsidiary of QIAGEN N.V.) today announced that they have entered into an agreement to develop a companion diagnostic test kit for PF-04948568 (CDX-110), an immunotherapy vaccine in development for the treatment of glioblastoma multiforme (GBM).
› Verified 5 days ago
| Provider Name | Christine Nabil Soliman |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1821404450 PECOS PAC ID: 5991077927 Enrollment ID: I20170824003698 |
News Archive
Even though patients receiving an implantable cardioverter-defibrillator for primary prevention often receive a dual-chamber ICD, an analysis that included more than 32,000 patients receiving an ICD without indications for pacing finds that the use of a dual-chamber device compared with a single-chamber device was associated with a higher risk of device-related complications and similar 1-year mortality and hospitalization outcomes, according to a study in the May 15 issue of JAMA.
Weill Cornell Medical College announced today that it has received a $100 million gift from longtime benefactors Joan and Sanford I. Weill and the Weill Family Foundation to launch the Medical College's $300 million Driving Discoveries, Changing Lives campaign dedicated to using the most advanced scientific approaches to rapidly translate research breakthroughs into innovative treatments and therapies for patients.
Genomic Health, Inc. today reported financial results and business progress for the quarter ended March 31, 2010.
Infinity Pharmaceuticals, Inc., an innovative drug discovery and development company, today announced that data from its Hsp90 chaperone and Hedgehog pathway inhibitor programs will be presented during the 2010 American Society of Clinical Oncology (ASCO) Annual Meeting being held in Chicago, Ill. from June 4 through June 8, 2010.
Pfizer Inc. and DxS (a wholly owned subsidiary of QIAGEN N.V.) today announced that they have entered into an agreement to develop a companion diagnostic test kit for PF-04948568 (CDX-110), an immunotherapy vaccine in development for the treatment of glioblastoma multiforme (GBM).
› Verified 5 days ago
News Archive
Even though patients receiving an implantable cardioverter-defibrillator for primary prevention often receive a dual-chamber ICD, an analysis that included more than 32,000 patients receiving an ICD without indications for pacing finds that the use of a dual-chamber device compared with a single-chamber device was associated with a higher risk of device-related complications and similar 1-year mortality and hospitalization outcomes, according to a study in the May 15 issue of JAMA.
Weill Cornell Medical College announced today that it has received a $100 million gift from longtime benefactors Joan and Sanford I. Weill and the Weill Family Foundation to launch the Medical College's $300 million Driving Discoveries, Changing Lives campaign dedicated to using the most advanced scientific approaches to rapidly translate research breakthroughs into innovative treatments and therapies for patients.
Genomic Health, Inc. today reported financial results and business progress for the quarter ended March 31, 2010.
Infinity Pharmaceuticals, Inc., an innovative drug discovery and development company, today announced that data from its Hsp90 chaperone and Hedgehog pathway inhibitor programs will be presented during the 2010 American Society of Clinical Oncology (ASCO) Annual Meeting being held in Chicago, Ill. from June 4 through June 8, 2010.
Pfizer Inc. and DxS (a wholly owned subsidiary of QIAGEN N.V.) today announced that they have entered into an agreement to develop a companion diagnostic test kit for PF-04948568 (CDX-110), an immunotherapy vaccine in development for the treatment of glioblastoma multiforme (GBM).
› Verified 5 days ago
Keith Ebilane, M.d., Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 13429 Hawthorne Blvd, Hawthorne, CA 90250 Phone: 310-644-8683 Fax: 310-644-0132 | |
Behavioral Health Services, Inc. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 12954 Hawthorne Blvd Ste 100, Hawthorne, CA 90250 Phone: 310-978-6900 Fax: 310-218-5484 | |
Ace Medical Group Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 4477 W 118th St, Suite 200, Hawthorne, CA 90250 Phone: 310-675-4440 Fax: 310-675-5816 | |
Ananias E. Ebilane, M.d., Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 13429 S Hawthorne Blvd, Hawthorne, CA 90250 Phone: 310-644-8683 Fax: 310-644-0132 | |
Lieu S. Nguyen, M.d., A Professional Corporation Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 15032 Prairie Ave, Hawthorne, CA 90250 Phone: 310-675-7343 Fax: 310-675-1951 | |
Mehmet C Demirozu M D Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 4477 W 118th St, Suite 303, Hawthorne, CA 90250 Phone: 310-644-9515 Fax: 310-644-3629 | |
Northeast Community Clinic Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 4455 W. 117th St Suite 105, Hawthorne, CA 90250 Phone: 424-456-6200 Fax: 424-456-6201 |